(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL-(S)-ALANYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID
Compound with spectra: 1 NMR
![(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL-(S)-ALANYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID](/api/compound/98qDZzAYi03.png?ph=true&h=300&w=458 "(2R,3R/2S,3S)-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL-(S)-ALANYL]-3-ETHOXYCARBONYL-AZIRIDINE-2-CARBOXYLIC-ACID")
| SpectraBase Compound ID | 98qDZzAYi03 |
|---|---|
| InChI | InChI=1S/2C23H31N3O8/c2*1-6-33-21(31)17-16(20(29)30)26(17)19(28)13(2)24-18(27)15(12-14-10-8-7-9-11-14)25-22(32)34-23(3,4)5/h2*7-11,13,15-17H,6,12H2,1-5H3,(H,24,27)(H,25,32)(H,29,30)/t2*13?,15?,16-,17-,26?/m10/s1 |
| InChIKey | PICFVNAEDGEOAA-WUEFPVFHSA-N |
| Mol Weight | 955.03 g/mol |
| Molecular Formula | C46H62N6O16 |
| Exact Mass | 954.42223 g/mol |
| Enantiomer InChIKey | PICFVNAEDGEOAA-VNLAXKFYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2R,3R/2S,3S)-DIBENZYL-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL]-AZIRIDINE-2,3-DICARBOXYLATE
TERT.-BUTYLOXYCARBONYL-O-BENZYL-L-SERYL-L-LEUCYL-L-PROLYL-METHYLESTER
TEOC-(3-NCP)ALA-PHE-VAL-OME
BEAUVERIOLIDE-VII
TERT-BUTYLOXYCARBONYL-[N(OMEGA)-NITRO]ARGININ-[N(OMEGA)-NITRO]ARGININ-PROLIN METHYL ESTER TRIPEPTIDE
CBZ-val-ser(TBDMS)-D-phe-ser(TBDMS)-ome
BEAUVEROLIDE-L;CYCLO-[3-HYDROXY-4-METHYLDECANOYL-L-PHENYL-ALANYL-L-ALANYL-D-LEUCYL]
BEAUVERIOLIDE-1
SOLONAMIDE-B
2-(3-Benzyl-2,5,6-trioxopiperazin-1-yl)propionic acid ethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| aziridinyl peptides as inhibitors of cysteine proteases: Effect of a free carboxylic acid function on inhibition | Bioorganic & Medicinal Chemistry | 2000 |